Classification of neuroblastomas based on an analysis of the expression of genes related to prognosis

Journal of Pediatric Surgery

Volumn 42, Issue 12, 2007, Pages 2046-2049

  Tajiri, Tatsuro ^a   Higashi, Mayumi ^a   Souzaki, Ryota ^a   Tatsuta, Kyousuke ^a   Kinoshita, Yoshiaki ^a   Taguchi, Tomoaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BIN1; Neuroblastoma; Neuronatin; Quantitative PCR; TrkA

Indexed keywords

PROTEIN TYROSINE KINASE A;

ARTICLE; BIN1 GENE; CANCER GRADING; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; INFANT; MALE; NEUROBLASTOMA; NEURONATIN BETA GENE; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRKA GENE; TUMOR CLASSIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROBABILITY; PROGNOSIS; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TISSUE CULTURE TECHNIQUES; TUMOR SUPPRESSOR PROTEINS;

EID: 36849008089     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2007.08.024     Document Type: Article

References (16)

1. Crist W.M., and Kun L.E. Common solid tumors of childhood. N Engl J Med 324 (1991) 461-471
2. Brodeur G.M. Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer 31 (1995) 505-510
3. Brodeur G.M., Maris J.M., Yamashiro D.J., et al. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19 (1997) 93-101
4. Hogarty M.D., Liu X., Thompson P.M., et al. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Med Pediatr Oncol 35 (2000) 559-562
5. Tajiri T., Tanaka S., Suita S., et al. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res 9 (2003) 3345-3355
6. Takita J., Ishii M., Tsutsumi S., et al. Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chromosomes Cancer 40 (2004) 120-132
7. Joseph R., Dou D., and Tsang W. Molecular cloning of a novel mRNA (neuronatin) that is highly expressed in neonatal mammalian brain. Biochem Biophys Res Commun 201 (1994) 1227-1234
8. Wijnholds J., Chowdhury K., Wehr R., et al. Segment-specific expression of the neuronatin gene during early hindbrain development. Dev Biol 171 (1995) 73-84
9. Dou D., and Joseph R. Cloning of human neuronatin gene and its localization to chromosome-20q 11.2-12: the deduced protein is a novel "proteolipid". Brain Res 723 (1996) 8-22
10. Higashi M., Tajiri T., Yoshiaki K., et al. Analysis of the neuronatin gene as a novel prognostic factor of neuroblastoma detected by microarray system. Jpn J Pediatr Oncol 42 (2005) 835-841
11. Brodeur G.M., Pritchard J., Berthold F., et al. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11 (1993) 1466-1477
12. Shimada H., Chatten J., and Newton W.A. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73 (1984) 405-416
13. Tajiri T., Tanaka S., Shono K., et al. Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 166 (2001) 89-94
14. Tanaka S., Tajiri T., Suita S., et al. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. J Pediatr Surg 39 (2004) 63-68
15. Tajiri T., Tanaka S., Higashi M., et al. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors. J Pediatr Surg 41 (2006) 560-566
16. Kaneko M., Nishihira H., Mugishima H., et al. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Med Pediatr Oncol 31 (1999) 1-7